http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2191594-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7832c494f42d6c61e6ddf6f6ee39cee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4e9c66c034126b7d2ca4f126f37681f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f0f688ef1f8324b9e0dd88b7bce621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe0d55ef87ed1e083002ed8f141307a |
| publicationDate | 2002-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2191594-C1 |
| titleOfInvention | Method and means for stimulating resistance to infection |
| abstract | FIELD: medicine. SUBSTANCE: method involves administering new interferon preparation enclosed in sublingual granules containing low doses of reaferon or realderon or interferon inhibitor like ridostine, laryfan, poludan, amixin and others. The other feature involves increasing resistance to viruses or other infectious agents like influenza, paragrippe viruses, enteroviruses, adenoviruses, herpes simplex viruses, Epstein-Bar viruses, coronal viruses, respiratory synticial viruses, chlamydies, mycoplasms. EFFECT: enhanced effectiveness in stimulating immunity. 46 cl, 4 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820970-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020005097-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-028541-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014035297-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2518314-C2 |
| priorityDate | 2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.